Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

Hepatology

Volumn 29, Issue 3, 1999, Pages 908-914

  Villano, Stephen A ^a   Vlahov, David ^b   Nelson, Kenrad E ^b   Cohn, Sylvia ^b   Thomas, David L ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; VIRUS RNA;

ADULT; ARTICLE; CHRONIC DISEASE; DNA SEQUENCE; DRUG USE; ELECTROIMMUNOASSAY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; IMMUNOBLOTTING; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; VIREMIA;

EID: 0033023854     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290311     Document Type: Article

References (11)

1. Alter MJ. Epidemiology of hepatitis C. HEPATOLOGY 1997;26(Suppl):62S-65S.
2. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. HEPATOLOGY 1997;26(Suppl):15S-20S.
3. Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, Purcell RH. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991;325:98-104.
4. Shimizu YK, Weiner AJ, Rosenblatt J, Wong DC, Shapiro M, Popkin TJ, Houghton M, et al. Early events in hepatitis C virus infection of chimpanzees. Proc Natl Acad Sci USA 1990;87:6441-6444.
5. Barrera JM, Bruguera M, Ercilla MG, Gil C, Celis R, Gil MP, Del Valle Onorato M, et al. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. HEPATOLOGY 1995;21:639-644.
6. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-1905.
7. Mattsson L, Sonnerborg A, Weiland O. Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markers. Liver 1993;13:274-278.
8. Garson JA, Tuke PW, Makris M, Briggs M, Machin SJ, Preston FE, Tedder RS. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis C virus contaminated factor VIII concentrates. Lancet 1990;336: 1022-1025.
9. Chang TT, Young KC, Yang YJ, Lei HY, Wu HL. Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection. HEPATOLOGY 1996;23:977-981.
10. Prince AM, Brotman B, Inchauspe G, Pascual D, Nasoff M, Hosein B, Wang CY. Patterns and prevalence of hepatitis C virus infection in posttransfusion non-A, non-B hepatitis. J Infect Dis 1993;167:1296-1301.
11. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996;98:706-714.